Fig. 5.
Time to progression survival according to the presence or absence of blood involvement (X2 = 4.5,P < .05).
Blood involvement was defined by either an excess of blood lymphocytes (> 5 × 109/L) or presence of abnormal cells.
Time to progression survival according to the presence or absence of blood involvement (X2 = 4.5,P < .05).
Blood involvement was defined by either an excess of blood lymphocytes (> 5 × 109/L) or presence of abnormal cells.
